DiscoverIDBR Infectious Disease Board ReviewPersistent low level HIV viremia - Trip Gulick, MD/ Michael Saag, MD
Persistent low level HIV viremia - Trip Gulick, MD/ Michael Saag, MD

Persistent low level HIV viremia - Trip Gulick, MD/ Michael Saag, MD

Update: 2024-07-29
Share

Description

A 42-year-old woman newly diagnosed with HIV (CD4 425, HIV RNA 73,000, genotype with wild-type virus) starts tenofovir alafenamide/emtricitabine/bictegravir and has the following virologic response:


Weeks of Therapy HIV Viral Load


4 weeks HIV RNA 9,400


8 weeks HIV RNA 1,050


16 weeks HIV RNA 105


24 weeks HIV RNA 90


36 weeks HIV RNA 67


48 weeks HIV RNA 82


In addition to reinforcing adherence, what would you recommend?




A. Add darunavir/ritonavir


B. Add etravirine


C. Add darunavir/ritonavir and etravirine


D. Switch bictegravir to darunavir/ritonavir


E. Continue current regimen




⁠www.idbrcourse.org/⁠  © 2024 IDBR LLC | All Rights Reserved



Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Persistent low level HIV viremia - Trip Gulick, MD/ Michael Saag, MD

Persistent low level HIV viremia - Trip Gulick, MD/ Michael Saag, MD

John Bennett, MD / Henry Masur, MD